What did the Japara (ASX:JHC) share price do after a big HY21 profit plunge?

The Japara Healthcare Ltd (ASX:JHC) share price was on watch today after reporting a large profit decline due to COVID-19.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Japara Healthcare Ltd (ASX: JHC) share price was on watch today after the company reported its FY21 half-year result.

Japara is one of the country's largest aged care operators.

What was in the Japara HY21 result?

Japara reported that it managed to grow its total revenue by 3.6% to $220.3 million due to increased government revenue and additional places.

The average occupancy for the period was 89.2%. The occupancy on 19 February 2021 was 87.3%. New places were added with the opening of the brownfield extension at Albury with 25 places.

However, there were $7 million of non-recurring COVID-19 pandemic specific expenses incurred, partially offset with a $1.6 million recognised reimbursement through the government grant program. Applications have been lodged to be reimbursed for the full expense incurred.

Earnings before interest, tax, depreciation and amortisation (EBITDA) dropped 67% to $8 million, impacted by COVID-19 costs. 'Recurring EBITDA' declined 29% to $15 million.

The net cash from operating activities more than halved to $24.7 million, down from $59.7 million in the prior corresponding period. This includes net refundable accommodation deposit (RAD) and independent living inflows (ILU) of $2.4 million.

It reported a statutory net loss after tax of $9.5 million. The prior corresponding result was a net profit of $5.4 million.

Balance sheet

Japara said that its net bank debt was $208 million at 31 December 2020, which includes $48 million of core net debt and $160 million of development debt.

It still has $137 million of available liquidity, however it isn't going to pay an interim dividend.

Japara share price

Despite such a large change in profit, the Japara share price was unmoved today. It's down 18% over the last year, though it has recovered significantly since the news of the effectiveness of the COVID-19 vaccines late last year. 

FY21 outlook

Japara said that progress continues to be made on the development program with an identified pipeline of 628 net new aged care places and three co-located seniors living development projects.

Its latest developments, being Trugo place in Victoria with 120 places and Corymbia in NSW with 102 places, are expected to open during the second half of FY21.

Japara said that the revenue and cost implications of COVID-19 remain uncertain. The funding environment continues to be challenging, with occupancy lower than the company was hoping.

Recently completed developments are expected to contribute to earnings.

Decisions on future development commencements have been deferred until the COVID-19 pandemic and economic outlook become more certain.

Japara's management is focused on the government response to the upcoming final report of the royal commission into aged care quality and safety.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher

These shares are having a better day than most today. But why?

Read more »

Three guys in shirts and ties give the thumbs down.
Share Fallers

Why Charter Hall Retail, DroneShield, FBR, and St Barbara shares are tumbling today

These shares are having a tough time on Tuesday. But why?

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these stocks.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

2 of the best ASX shares to buy in 2025

Bell Potter is feeling bullish on these shares as the new year approaches.

Read more »

A happy man and woman on a computer at Christmas, indicating a positive trend for retail shares.
Share Market News

5 things to watch on the ASX 200 on Tuesday

Will the market give investors a little Christmas present today?

Read more »

Young boy in business suit punches the air as he finishes ahead of another boy in a box car race.
Opinions

Why I think these 2 ASX 300 stocks will beat the market in 2025

I’m very optimistic about a few ASX growth shares.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why EML, GQG Partners, IGO, and Integrated Research shares are sinking today

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of…

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why EOS, News Corp, Polynovo, and Pro Medicus shares are roaring higher today

These shares are starting the week positively. But why?

Read more »